Effects of chemokines on proliferation and apoptosis of human mesangial cells

BMC Nephrology

Volumn 5, Issue , 2004, Pages

  Wörnle, Markus ^a   Schmid, Holger ^a   Merkle, Monika ^a   Banas, Bernhard ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; FAS ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GLOMERULUS; HOMEOSTASIS; HUMAN; HUMAN CELL; MESANGIUM CELL; NEPHRITIS; PODOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STAINING;

ANTIGENS, CD95; APOPTOSIS; CELL DIVISION; CELL LINE, TRANSFORMED; CHEMOKINE CCL21; CHEMOKINE CCL5; CHEMOKINE CXCL10; CHEMOKINES, CC; CHEMOKINES, CXC; CULTURE MEDIA, SERUM-FREE; GLOMERULAR MESANGIUM; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1; RECEPTORS, CCR1; RECEPTORS, CCR7; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR3; TUMOR NECROSIS FACTOR-ALPHA;

EID: 13444282267     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-5-8     Document Type: Article

References (40)

1. Luster AD: Chemokines: Chemotactic cytokines that mediate inflammation. N Engl J Med 1998, 338:436-445.
2. Muller A, Homey B, Soto N, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
3. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura K, Matsushima N, Yoshida N, Nishikawa S, Kishimoto T, Nagasawa T: The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998, 393:591-594.
4. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littmann DR: Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.
5. Mackay CR, Chemokines: What chemokine is that? Curr Biol 1997, 7:R384-386.
6. Rollins BJ: Chemokines. Blood 1997, 90:909-928.
7. Murphy PM, Baggiolini M, Charo IF, Herbert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA: International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000, 52:145-176.
8. Segerer S, Nelson PJ, Schlöndorff D: Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000, 11:152-176.
9. Banas B, Luckow B, Möller M, Klier C, Nelson PJ, Schadde E, Brigl M, Halevy D, Holthöfer H, Reinhart B, Schlöndorff D: Chemokine and chemokine receptor expression in a novel human mesangial cell line. J Am Soc Nephrol 1999, 10:2314-2322.
10. Gomez-Chiarri M, Hamilton TA, Egido J, Emancipator SN: Expression of IP-10, a lipopolysaccharide- and interferon-gamma-inducible protein, in murine mesangial cells in culture. Am J Pathol 1993, 142:433-439.
11. Romagnani P, Beltrame C, Annunziato F, Lasagni L, Luconi M, Galli G, Cosmi L, Maggi E, Salvadori M, Pupilli C, Serio M: Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis. J Am Soc Nephrol 1999, 10:2518-2526.
12. Banas B, Wörnle M, Berger T, Nelson PJ, Cohen CD, Kretzler M, Pfirstinger J, Mack M, Lipp M, Gröne HJ, Schlöndorff D: Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis and tissue homeostasis. J Immunol 2002, 168:4301-4307.
13. Harrison DJ: Cell death in the diseased glomerulus. Histopathology 1988, 12:679-683.
14. Schlöndorff D, Nelson PJ, Luckow B, Banas B: Chemokines and renal disease. Kidney Int 1997, 51:610-621.
15. Heeg K, Reimann J, Kabelitz D, Hardt C, Wagner H: A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies. J Immunol Methods 1985, 77:237-246.
16. Gonzales-Cuadrado S, Lopez-Armada MJ, Gomez-Guerrero C, Subira D, Garcia-Sahuquillo A, Ortiz-Gonzales A, Neilson EG, Egido J, Ortiz A: Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells. Kidney Int 1996, 49:1064-1070.
17. Berger T, Brigl M, Hermann JM, Vielhauer V, Luckow B, Schlöndorff D, Kretzler M: The apoptosis mediator mDAP-3 is a novel member of a conserved family of mitochondrial proteins. J Cell Sci 2000, 113:3603-3612.
18. Fernandes-Alnemri T, Litwack G, Alnemeri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 1994, 269:30761-30764.
19. Roos A, Sato T, Maier H, van Kooten C, Daha MR: Induction of renal cell apoptosis by antibodies and complement. Exp Nephrol 2001, 9:65-70.
20. Krammer PH: CD95's deadly mission in the immune system. Nature 2000, 407:789-795.
21. Ortiz A, Lorz C, Egido J: New kids in the block: the role of FasL and Fas in kidney damage. J Nephrol 1999, 12:150-158.
22. Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomen with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
23. Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne VL, Culhane AC, Wiliams GT: Apoptosis: molecular regulation of cell death. Eur J Biochem 1996, 236:1-26.
24. Baker AJ, Mooney A, Hughes J, Lombardi D, Jonson RJ, Savill J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994, 94:2105-2116.
25. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in the repair of experimental proliverative glomerulonephritis. Kidney Int 1995, 47:114-121.
26. Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in progressive crescent glomerulonephritis. Lab Invest 1996, 74:941-951.
27. Ortiz A, Lorz C, Justo P, Catalan MP, Egido J: Contribution of apoptotic cell death to renal injury. J Cell Mol Med 2001, 5:18-32.
28. Wang W, Tzanidis A, Divjak M, Thomson NM, Stein-Oakley AN: Altered signaling and regulatory mechanisms of apoptosis in focal and segmental glomerulosclerosis. J Am Soc Nephrol 2001, 12:1422-1433.
29. Kitching AR, Katerelos M, Mudge SJ, Tipping PG, Power DA, Holdsworth SR: Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis. Clin Exp Immunol 2002, 128:36-43.
30. Feld SM, Hirschberg R, Artishevsky A, Nast C, Adler SG: Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen. Kidney Int 1995, 48:45-51.
31. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF, Johnson RJ: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 1993, 92:2952-2962.
32. Sano H, Ueda Y, Takakura N, Takemura G, Doi T, Kataoka H, Murayama T, Xu Y, Sudo T, Nishikawa S, Nishikawa S, Fujiwara H, Kita T, Yokode M: Blockade of platelet-derived growth factor receptor-beta pathway induces apoptosis of vascular endothelial cells and disrupts glomerular capillary formation in neonatal mice. Am J Pathol 2002, 161:135-143.
33. Campbell JJ, Bowman EP, Murphy K, Youngman KR, Siani MA, Thompson DA, Wu L, Zlotnik A, Butcher EC: 6-C-kine (SLC), a lymphocyte adhesion triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7. J Cell Biol 1998, 141:1053-1059.
34. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Ait-Yahia S, Briere F, Zlotnik A, Lebecque S, Caux C: Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998, 188:373-386.
35. Cyster JG: Leukocyte migration: scent of the T zone. Curr Biol 2000, 10:R30-33.
36. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
37. Boehme SA, Lio FM, Maciejewski-Lenoir D, Bacon KB, Conlon PJ: The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol 2000, 165:397-403.
38. Anders HJ, Vielhauer V, Kretzler M, Cohen CD, Segerer S, Luckow B, Weller L, Gröne HJ, Schlöndorff D: Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J Am Soc Nephrol 2001, 12:919-931.
39. Topham PS, Csizmadia V, Soler D, Hines D, Gerard CJ, Salant DJ, Hancock WW: Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest 1999, 104:1549-1557.
40. Anders HJ, Frink M, Linde Y, Banas B, Wörnle M, Cohen CD, Vielhauer V, Nelson PJ, Grone HJ, Schlöndorff D: CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol 2003, 170:5658-5666.